JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

B1618 Fesoterodine Fumarate

Summary: Muscarinic AChR receptor antagonist

≥52.4 mg/mL
B1864 Valganciclovir HCl

Summary: prodrug for ganciclovir

insoluble in EtOH; ≥11.4 mg/mL
B2280 Rufinamide

Summary: voltage-gated sodium channel blocker

insoluble in H2O; insoluble in EtOH; ≥11.25 mg/mL
B1529 Gabapentin HCl

Summary: GABA analog
B1867 Verapamil HCl
1 Citation

Target: Voltage-gated Calcium Channels (CaV)

Summary: L-type calcium channel blocker

≥14.45 mg/mL
B1204 Ondansetron hydrochloride dihydrate

Summary: 5-HT3 receptor antagonist
B1513 Toremifene Citrate

Target: Estrogen and Related Receptors

Summary: Oral selective estrogen receptor modulator (SERM)

≥24.15 mg/mL
B1359 Formoterol fumarate
2 Citation

Summary: A long-acting β2-adrenergic receptor agonist

≥44.7 mg/mL
B2092 Doxifluridine

Summary: oral prodrug of the antineoplastic agent 5-fluorouracil (5-FU)

insoluble in EtOH; ≥10 mg/mL
B1414 Azelnidipine

Summary: L-type calcium channel blocker;antihypertensive

≥27.15 mg/mL